USE OF PHARMACEUTICAL COMPOUND CONTAINING CROTOXIN FOR THE TREATMENT OF MUSCLE DYSTONIAS

摘要

The present invention is related to the use of a pharmaceutical compound containing a toxin extracted from the rattlesnake (Crotalus durissus terrificus) venom, known as crotoxin, which can act as an agent provoking muscular paralysis. Medical uses of this invention formulation are described, which was developed for muscular pathological conditions whose muscular paralysis is desired, such as strabismus, blepharospams, and nystagmus, among others.